1. Home
  2. IMCR vs HLMN Comparison

IMCR vs HLMN Comparison

Compare IMCR & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.13

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$9.09

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCR
HLMN
Founded
2008
1964
Country
United Kingdom
United States
Employees
493
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMCR
HLMN
Price
$36.13
$9.09
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$67.00
$12.20
AVG Volume (30 Days)
259.5K
984.6K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
388.43
EPS
N/A
0.19
Revenue
$379,590,000.00
$1,536,647,000.00
Revenue This Year
$32.28
$7.97
Revenue Next Year
$10.66
$7.80
P/E Ratio
N/A
$47.85
Revenue Growth
28.11
4.47
52 Week Low
$23.15
$6.55
52 Week High
$40.72
$10.64

Technical Indicators

Market Signals
Indicator
IMCR
HLMN
Relative Strength Index (RSI) 48.05 53.89
Support Level $35.41 $8.81
Resistance Level $37.25 $9.19
Average True Range (ATR) 1.58 0.25
MACD -0.18 0.01
Stochastic Oscillator 20.63 59.88

Price Performance

Historical Comparison
IMCR
HLMN

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: